日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6

既往心血管疾病史和基线体重指数对心肾结局的影响：索玛鲁肽与安慰剂的比较：SUSTAIN 6 和 PIONEER 6 研究的汇总事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16621
Zhou, Jingmin; Husain, Mansoor; Li, Yang; Liu, Wenyan; Shen, Zewei; Vilsbøll, Tina; Ge, Junbo
心血管疾病
心血管
发表日期：2025
文献求助 收藏

Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF

DEFINE-HF 和 PRESERVED-HF 研究中基线肾功能以及达格列净对心力衰竭患者健康状况的影响

期刊:Esc Heart Failure
影响因子:3.7
doi:10.1002/ehf2.15184
Ambrosy, Andrew P; Sauer, Andrew J; Patel, Shachi; Windsor, Sheryl L; Borlaug, Barry A; Husain, Mansoor; Inzucchi, Silvio E; Kitzman, Dalane W; McGuire, Darren K; Shah, Sanjiv J; Sharma, Kavita; Umpierrez, Guillermo; Kosiborod, Mikhail N
心力衰竭
心血管
发表日期：2025
文献求助 收藏

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6

按基线年龄划分的司美格鲁肽治疗的心血管、代谢和安全性结局：SUSTAIN 6 和 PIONEER 6 的事后分析

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-024-01659-7
Bain, Stephen C; Belmar, Nicolas; Hoff, Søren T; Husain, Mansoor; Rasmussen, Søren; Vilsbøll, Tina; Petrie, Mark C
代谢
发表日期：2025
文献求助 收藏

Real-world effectiveness of early revascularization in stable coronary artery disease with moderate or severe ischemia

早期血运重建治疗中度或重度缺血的稳定性冠状动脉疾病的实际疗效

期刊:American Heart Journal Plus
影响因子:1.8
doi:10.1016/j.ahjo.2025.100596
Gerodias, Ferdinand Jr; Iwanochko, Robert M; Austin, Peter C; Wang, Xuesong; Džavík, Vladimír; Goodman, Shaun G; Udell, Jacob A; Ouzounian, Maral; Ross, Heather J; Godoy, Lucas C; Amad, Hani; Husain, Mansoor; Lee, Douglas S
发表日期：2025
文献求助 收藏

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF

达格列净与射血分数降低型心力衰竭（HFrEF）患者心肾结局和载脂蛋白M水平的相关性：来自DEFINE-HF研究的启示

期刊:JACC Advances
影响因子:
doi:10.1016/j.jacadv.2025.101800
Sauer, Andrew J; Chang, Joycie; Fu, Zhuxuan; Valenzuela Ripoll, Carla; Cho, Yoonje; Guo, Zhen; Jones, Philip; Selvaraj, Senthil; Windsor, Sheryl L; Husain, Mansoor; Inzucchi, Silvio E; McGuire, Darren K; Pitt, Bertram; Scirica, Benjamin M; Austin, Bethany A; Umpierrez, Guillermo; Tran, Sinh; Dahlbäck, Björn; Javaheri, Ali; Kosiborod, Mikhail N
心力衰竭
心血管
发表日期：2025
文献求助 收藏

Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement

临床分期指导代谢性疾病及其后遗症的治疗：欧洲动脉粥样硬化学会共识声明

期刊:European Heart Journal
影响因子:
doi:10.1093/eurheartj/ehaf314
Romeo, Stefano; Vidal-Puig, Antonio; Husain, Mansoor; Ahima, Rexford; Arca, Marcello; Bhatt, Deepak L; Diehl, Anna Mae; Fontana, Luigi; Foo, Roger; Frühbeck, Gema; Kozlitina, Julia; Lonn, Eva; Pattou, Francois; Plat, Jogchum; Quaggin, Susan E; Ridker, Paul M; Rydén, Mikael; Segata, Nicola; Tuttle, Katherine R; Verma, Subodh; Roeters van Lennep, Jeanine; Benn, Marianne; Binder, Christoph J; Jamialahmadi, Oveis; Perkins, Rosie; Catapano, Alberico L; Tokgözoğlu, Lale; Ray, Kausik K
心血管
动脉粥样硬化
代谢
发表日期：2025
文献求助 收藏

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

SGLT2抑制剂达格列净对射血分数谱系心力衰竭患者的代谢影响

期刊:Circulation-Heart Failure
影响因子:8.4
doi:10.1161/CIRCHEARTFAILURE.124.011980
Selvaraj, Senthil; Patel, Shachi; Sauer, Andrew J; McGarrah, Robert W; Jones, Philip; Kwee, Lydia Coulter; Windsor, Sheryl L; Ilkayeva, Olga; Muehlbauer, Michael J; Newgard, Christopher B; Borlaug, Barry A; Kitzman, Dalane W; Shah, Sanjiv J; Margulies, Kenneth B; Husain, Mansoor; Inzucchi, Silvio E; McGuire, Darren K; Lanfear, David E; Javaheri, Ali; Umpierrez, Guillermo; Mentz, Robert J; Sharma, Kavita; Kosiborod, Mikhail N; Shah, Svati H
SGLT2
心力衰竭
心血管
代谢
发表日期：2024
文献求助 收藏

Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor

接受索玛鲁肽或二肽基肽酶 4 抑制剂治疗的美国 2 型糖尿病患者发生中风的风险

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-023-02750-4
Evans, Marc; Husain, Mansoor; Srivastava, Ayush; Mangla, Kamal Kant; Kuhlman, Anja Birk; Lingvay, Ildiko
代谢
糖尿病
心血管
中风
发表日期：2024
文献求助 收藏

Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review

代谢功能障碍相关性脂肪性肝炎患者与代谢功能障碍相关性脂肪肝及其他肝病患者心血管疾病的比较：一项系统评价

期刊:American Heart Journal Plus
影响因子:1.8
doi:10.1016/j.ahjo.2024.100386
Sanyal, Arun J; Husain, Mansoor; Diab, Crystel; Mangla, Kamal Kant; Shoeb, Ahsan; Lingvay, Ildiko; Tapper, Elliot B
心血管疾病
心血管
代谢
脂肪肝
肝炎
发表日期：2024
文献求助 收藏

Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials

钠-葡萄糖协同转运蛋白2抑制剂治疗心力衰竭患者生活质量的种族差异：CHIEF-HF、DEFINE-HF和PRESSERVED-HF试验的患者水平荟萃分析

期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.122.063263
Gupta, Kashvi; Spertus, John A; Birmingham, Mary; Gosch, Kensey L; Husain, Mansoor; Kitzman, Dalane W; Pitt, Bertram; Shah, Sanjiv J; Januzzi, James L; Lingvay, Ildiko; Butler, Javed; Kosiborod, Mikhail; Lanfear, David E
心血管
心力衰竭
发表日期：2023
文献求助 收藏